PulseAugur
EN
LIVE 11:14:12
ENTITY intismeran autogene

intismeran autogene

PulseAugur coverage of intismeran autogene — every cluster mentioning intismeran autogene across labs, papers, and developer communities, ranked by signal.

Show in brief
Total · 30d
2
2 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
0
0 over 90d
TIER MIX · 90D
TOPICS
TIMELINE
  1. 2026-08-28 research_milestone Moderna and Merck's personalized mRNA cancer vaccine, Intismeran Autogene, achieved positive results in Phase III clinical trials for melanoma. source
  2. 2026-08-19 research_milestone Merck and Moderna announced encouraging results from a Phase III clinical trial for their experimental melanoma vaccine, intismeran autogene. source
  3. 2026-08-19 research_milestone Merck and Moderna announced positive Phase 3 trial results for their personalized mRNA melanoma vaccine, intismeran autogene, in combination with Keytruda. source
RECENT · PAGE 1/1 · 2 TOTAL
  1. TOOL · CL_223489 ·

    AI-developed cancer vaccine shows promise, but high cost raises accessibility concerns · 1 source tracked

    Moderna and Merck's personalized mRNA cancer vaccine, Intismeran Autogene, has shown promising results in Phase III clinical trials for melanoma, marking a significant milestone as the first individualized neoantigen th…
  2. RESEARCH · CL_209401 ·

    Merck, Moderna melanoma vaccine shows promise in Phase 3 trial

    Merck and Moderna have announced promising results from a Phase 3 clinical trial for their personalized mRNA vaccine, intismeran autogene, when used in combination with Merck's Keytruda immunotherapy for melanoma patien…